Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,500
Closed -$2.05M 673
2017
Q4
$2.05M Buy
+3,500
New +$2.26M 0.1% 148
2017
Q3
Sell
-3,036
Closed -$2.63M 692
2017
Q2
$2.63M Buy
3,036
+2,684
+763% +$2.25M 0.13% 138
2017
Q1
$298K Sell
352
-2,897
-89% -$2.4M 0.02% 419
2016
Q4
$2.48M Sell
3,249
-4,699
-59% -$3.55M 0.14% 135
2016
Q3
$6.52M Buy
7,948
+7,086
+822% +$6.12M 0.32% 58
2016
Q2
$719K Sell
862
-7,104
-89% -$5.93M 0.05% 284
2016
Q1
$7.3M Buy
+7,966
New +$7.62M 0.45% 50

Other funds holding AGN.PRA

CSS LLC's AGN.PRA Position: Q1 2018 in Review

CSS LLC sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 3,500 shares — an estimated $2.05M sold.

CSS LLC first reported a position in AGN.PRA in Q1 2016 and held it in 7 quarters. The position peaked at $7.3M in Q1 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • CSS LLC reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • CSS LLC sold 3,500 Allergan plc shares in Q1 2018, an estimated $2.05M.
  • CSS LLC first reported a position in Allergan plc in Q1 2016 and held it in 7 quarters.
  • CSS LLC's Allergan plc position peaked at $7.3M in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on CSS LLC's 13F filing for Q1 2018, filed 15 May 2018.